US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

5.49

-0.4250-7.19%

Post-market: 5.48-0.0050-0.09%16:36 EDT

Volume:907.14K

Turnover:4.97M

Market Cap:377.43M

PE:-2.26

High:5.94

Open:5.91

Low:5.30

Close:5.91

Loading ...

Overview Company News Filings

EyePoint Pharmaceuticals Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating

Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k

Simply Wall St.

Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ...

EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates

Scotiabank Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance

EyePoint Pharmaceuticals' $371M Of Cash And Investments On December 31, 2024, Providing Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet AMD Data Expected In 2026

EyePoint Pharmaceuticals Q4 2024 GAAP EPS $(0.64) Misses $(0.51) Estimate, Sales $11.59M Beat $11.09M Estimate

EyePoint Pharmaceuticals Inc: $371 Mln of Cash and Investments on Dec 31, 2024, Providing Cash Runway Into 2027

THOMSON REUTERS

EyePoint Pharmaceuticals Q4 Product Sales USD 774 Thousand

THOMSON REUTERS

EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments

Calendar of U.S. Earnings Expected in the Week Ahead

EyePoint Announces Participation at Upcoming Investor Conferences

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) May Have Run Too Fast Too Soon With Recent 30% Price Plummet

Simply Wall St.

EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025

EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference

EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EYPT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EYPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":5.485,"timestamp":1747252800000,"preClose":5.91,"halted":0,"volume":907138,"hourTrading":{"tag":"盘后","latestPrice":5.48,"preClose":5.485,"latestTime":"16:36 EDT","volume":176655,"amount":968947.675,"timestamp":1747255000596},"delay":0,"floatShares":43630232,"shares":68811736,"eps":-2.425671,"marketStatus":"Closed","change":-0.425,"latestTime":"05-14 16:00:00 EDT","open":5.91,"high":5.94,"low":5.3,"amount":4969688.404788,"amplitude":0.108291,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.425671,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747296000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.91,"preHourTrading":{"tag":"盘前","latestPrice":5.94,"preClose":5.91,"latestTime":"08:00 EDT","volume":838,"amount":4977.72,"timestamp":1747224000233},"postHourTrading":{"tag":"盘后","latestPrice":5.48,"preClose":5.485,"latestTime":"16:36 EDT","volume":176655,"amount":968947.675,"timestamp":1747255000596},"volumeRatio":1.551711,"impliedVol":1.1161,"impliedVolPercentile":0.836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","floatShares":43630232,"roa":"-29.16%","roe":"-53.54%","lyrEps":-2.324594,"volumeRatio":1.551711,"shares":68811736,"dividePrice":0,"high":5.94,"amplitude":0.108291,"preClose":5.91,"low":5.3,"week52Low":3.91,"pbRate":"1.26","psRate":"6.73","week52High":13.985,"institutionHeld":0.3776,"latestPrice":5.485,"eps":-2.425671,"divideRate":0,"volume":907138,"delay":0,"ttmEps":-2.425671,"open":5.91,"prevYearClose":7.45,"prevWeekClose":5.81,"prevMonthClose":6.82,"prevQuarterClose":5.42,"fiveDayClose":6.09,"twentyDayClose":5.67,"sixtyDayClose":6.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYPT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517315978","title":"EyePoint Pharmaceuticals Price Target Maintained With a $22.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517315978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517315978?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:02","pubTimestamp":1741262520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EYPT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 07:02 ET (12:02 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2517155981","title":"EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517155981","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517155981?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:38","pubTimestamp":1741261127,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals (EYPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yi Chen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/eyepoint-pharmaceuticals-promising-clinical-progress-and-strong-financial-position-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/eyepoint-pharmaceuticals-promising-clinical-progress-and-strong-financial-position-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","EYPT"],"gpt_icon":0},{"id":"2517559941","title":"Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k","url":"https://stock-news.laohu8.com/highlight/detail?id=2517559941","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517559941?lang=en_us&edition=fundamental","pubTime":"2025-03-06 18:34","pubTimestamp":1741257272,"startTime":"0","endTime":"0","summary":"Some of the losses seen by insiders who purchased US$184.5k worth of EyePoint Pharmaceuticals, Inc.  shares over the past year were recovered after the stock increased by 12% over the past week. The purchase, however, has proven to be a pricey bet, with losses currently totalling US$32k.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.EyePoint Pharmaceuticals Insider Transactions Over The Last Year. It doesn't really mean much that no insider has traded EyePoint Pharmaceuticals shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. The transactions are fine but it'd be more encouraging if EyePoint Pharmaceuticals insiders bought more shares in the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/despite-recent-gains-eyepoint-pharmaceuticals-103432769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4585","BK4588","BK4007","EYPT","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517418136","title":"Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2517418136","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517418136?lang=en_us&edition=fundamental","pubTime":"2025-03-06 15:14","pubTimestamp":1741245279,"startTime":"0","endTime":"0","summary":"George Elston; Chief Financial Officer, Executive Vice President; EyePoint Pharmaceuticals Inc. Jay Duker; President, Chief Executive Officer; EyePoint Pharmaceuticals Inc. Ramiro Ribeiro; Chief Medical Officer; EyePoint Pharmaceuticals Inc. Colleen Kusy; Senior Research Analyst; Robert W. Baird & Co Inc. Good morning. My name is Michelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint fourth quarter and full year 2024 financial results and recent corporate development conference call. . Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to George Elston, Executive Vice President and Chief Financial Officer of EyePoint. Please go ahead, sir.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-eyepoint-pharmaceuticals-inc-071439006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EYPT"],"gpt_icon":0},{"id":"2517808181","title":"EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2517808181","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517808181?lang=en_us&edition=fundamental","pubTime":"2025-03-06 15:06","pubTimestamp":1741244803,"startTime":"0","endTime":"0","summary":"Total Net Revenue : $11.6 million, compared to $14 million in Q4 2023.Net Product Revenue : $0.8 million, compared to $0.7 million in Q4 2023.Net Revenue from Royalties and Collaborations : $10.8 million, compared to $13.3 million in Q4 2023.Operating Expenses : $56.8 million, compared to $30.4 million in Q4 2023.Net Loss : $41.4 million or $0.64 per share, compared to $14.1 million or $0.33 per share in Q4 2023.Total Net Revenue : $43.3 million, compared to $46 million in 2023.Net Product Revenue : $3.2 million, compared to $14.2 million in 2023.Net Revenue from Royalties and Collaborations : $40.1 million, compared to $31.8 million in 2023.Net Loss : $130.9 million or $2.32 per share, compared to $70.8 million or $1.82 per share in 2023.Cash and Investments : $371 million, compared to $331 million at the end of 2023.GuruFocus has detected 5 Warning Signs with EYPT.EyePoint Pharmaceuticals Inc  advanced its DURAVYU therapy into Phase 3 clinical trials for wet age-related macular degen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-pharmaceuticals-inc-eypt-q4-070643945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EYPT"],"gpt_icon":0},{"id":"2517192863","title":"EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192863","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517192863?lang=en_us&edition=fundamental","pubTime":"2025-03-06 02:34","pubTimestamp":1741199663,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryEyePoint Pharmaceuticals Inc EYPT.OQ reported a quarterly adjusted loss of 64 cents per share for the q","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL5N3PO1ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2517650943","title":"EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517650943","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517650943?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:25","pubTimestamp":1741181104,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals  came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -56.10%. A quarter ago, it was expected that this drug delivery technology company would post a loss of $0.48 per share when it actually produced a loss of $0.54, delivering a surprise of -12.50%.EyePoint Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $11.59 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 21.04%. This compares to year-ago revenues of $14.03 million. The company has not been able to beat consensus revenue estimates over the last four quarters.EyePoint Pharmaceuticals shares have lost about 18.4% since the beginning of the year versus the S&P 500's decline of -1.8%.While EyePoint Pharmac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-pharmaceuticals-eypt-reports-q4-132504756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EYPT"],"gpt_icon":0},{"id":"2517112749","title":"Scotiabank Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517112749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517112749?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:16","pubTimestamp":1741180611,"startTime":"0","endTime":"0","summary":"In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), with a pric...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-sticks-to-their-buy-rating-for-eyepoint-pharmaceuticals-eypt-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-sticks-to-their-buy-rating-for-eyepoint-pharmaceuticals-eypt-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EYPT"],"gpt_icon":0},{"id":"2517916281","title":"EyePoint Pharmaceuticals: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916281","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916281?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:34","pubTimestamp":1741178059,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass.  — WATERTOWN, Mass.  — EyePoint Pharmaceuticals  on Wednesday reported a loss of $41.4 million in its fourth quarter.On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 64 cents.The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.The drug delivery technology company posted revenue of $11.6 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $14.7 million.For the year, the company reported a loss of $130.9 million, or $2.32 per share. Revenue was reported as $43.3 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-pharmaceuticals-q4-earnings-snapshot-123419990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EYPT"],"gpt_icon":0},{"id":"2517913186","title":"EyePoint Pharmaceuticals' $371M Of Cash And Investments On December 31, 2024, Providing Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet AMD Data Expected In 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913186","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913186?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:02","pubTimestamp":1741176135,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals' $371M Of Cash And Investments On December 31, 2024, Providing Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet AMD Data Expected In 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/03/44137764/eyepoint-pharmaceuticals-371m-of-cash-and-investments-on-december-31-2024-providing-cash-runway-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880398554.USD","BK4566","LU1242518931.SGD","BK4141","LU0823434740.USD","BK4178","BK4573","GFS","LU1951198990.SGD","BK4605","LU0198837287.USD","BK4534","LU1064131342.USD","LU0719512351.SGD","BK4588","LU0127658192.USD","LU0390134368.USD","LU0823421416.USD","EYPT","LU0889565833.HKD","LU1303367103.USD","LU0109392836.USD","LU1923623000.USD","IE00B5949003.HKD","BK4554","BK4575","BK4529","LU2098885051.SGD","BK4543","LU1852331112.SGD","IE0009356076.USD","LU0081259029.USD","IE0004445239.USD","IE00BMPRXR70.SGD","LU0082616367.USD","LU1880398471.USD","BK4512","BK4007","LU0823421333.USD","LU1951200564.SGD","LU2458330243.SGD","LU2264538146.SGD","BK4532","LU1988902786.USD","LU0320765992.SGD","IE00BMPRXN33.USD","LU2458330169.SGD","LU1803068979.SGD"],"gpt_icon":0},{"id":"2517913184","title":"EyePoint Pharmaceuticals Q4 2024 GAAP EPS $(0.64) Misses $(0.51) Estimate, Sales $11.59M Beat $11.09M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913184","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913184?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:01","pubTimestamp":1741176078,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.51) by 25.49 percent. This is a 93.94 percent decrease over losses of $(0.33) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44137735/eyepoint-pharmaceuticals-q4-2024-gaap-eps-0-64-misses-0-51-estimate-sales-11-59m-beat-11-09m-estima","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EyePoint Pharmaceuticals Q4 2024 GAAP EPS $(0.64) Misses $(0.51) Estimate, Sales $11.59M Beat $11.09M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"2517913922","title":"EyePoint Pharmaceuticals Inc: $371 Mln of Cash and Investments on Dec 31, 2024, Providing Cash Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913922?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLXB5A1E5:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU0320765992.SGD","LU0889565916.HKD","BK4007","LU0109394709.USD","EYPT","BK4585"],"gpt_icon":0},{"id":"2517136209","title":"EyePoint Pharmaceuticals Q4 Product Sales USD 774 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136209?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nPLXB5A1E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYPT","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2517222913","title":"EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2517222913","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517222913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"– Enrollment exceeding expectations in DURAVYU Phase 3 wet AMD clinical trials with LUGANO over 50% enrolled and LUCIA recruiting ahead of schedule –。– Positive Phase 2 VERONA clinical trial of DURAVYU for DME met primary and secondary endpoints –。– $371 million of cash and investments on December 31, 2024, providing cash runway into 2027 beyond topline DURAVYU Phase 3 wet AMD data expected in 2026 –。WATERTOWN, Mass., March 05, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced financial results for the fourth quarter and full-year endedDecember 31, 2024,and highlighted recent corporate developments.CST improvement of 117.4 microns versus 43.7 microns for aflibercept control","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-reports-fourth-quarter-full-120000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823434740.USD","BK4588","LU0109392836.USD","LU1242518931.SGD","IE0004445239.USD","LU1880398554.USD","LU0823434583.USD","LU1064131342.USD","LU1988902786.USD","LU2250418816.HKD","LU2264538146.SGD","LU0056508442.USD","BK4543","LU0889565833.HKD","LU0198837287.USD","LU0889565916.HKD","LU1923623000.USD","LU1989764664.SGD","BK4512","BK4605","LU1880398471.USD","BK4532","LU0719512351.SGD","LU1951198990.SGD","LU0081259029.USD","LU0979878070.USD","LU1303367103.USD","BK4534","GFS","LU0082616367.USD","BK4554","BK4585","IE00BMPRXN33.USD","IE00BMPRXR70.SGD","EYPT","LU0390134368.USD","LU2098885051.SGD","LU1852331112.SGD","LU1242518857.USD","LU1951200564.SGD","LU0642271901.SGD","LU0823421416.USD","BK4573","BK4529","LU0127658192.USD","IE0009356076.USD","BK4575","LU2054465674.USD","LU0109394709.USD"],"gpt_icon":1},{"id":"2517990373","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517990373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517990373?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:00","pubTimestamp":1741172400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Abercrombie & Fitch                              4Q      3.54   7:30 AM. ·ACRES Cmmcl Rlty                                 4Q       .36   4:15 PM. ·Descartes Sys Gp                                4Q       .43   5:00 PM. ·Dine Brands Global                               4Q      1.34   7:00 AM. ·Foot Locker Inc.                                  4Q       .72   6:45 AM. ·Forge Global Hldgs                              4Q      (.09)  4:10 PM. ·Global Ship Lease                                4Q      2.31   8:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT","AMTX","SKLZ","CNQ","FDUS","FRGE","IMRX","KR","FSM","RSKD","HDSN","DIN","SNBR","DOMO","ALGS","MRX","EYPT","OCGN","DESP","CRVS","LB","FL","GAP","TREE","ALTG","ATXS","CAPR","SVCO","BALY","LPSN","PAM","BF.B","MRVL","QNRX","ARQ","VEEV","AKA","BF.A","TCRX","ZYME","GRND","ATER","ARCT","ZS","HIPO","AVGO","ECOR","ALNT","CRMT"],"gpt_icon":1},{"id":"2516620433","title":"EyePoint Announces Participation at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516620433","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516620433?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., March 04, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming investor conferences:. Leerink Partners Global Healthcare Conference Forum: Corporate PresentationDate: Tuesday, March 11, 2025Time: 4:20 p.m. ET. Barclays 27th Annual Global Healthcare ConferenceForum: Fireside ChatDate: Wednesday, March 12, 2025Time: 3:00 p.m. ET. DURAVYU has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential approval is uncertain.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-announces-participation-upcoming-investor-120000002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","EYPT","BK4585","BK4007"],"gpt_icon":0},{"id":"2514381513","title":"EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) May Have Run Too Fast Too Soon With Recent 30% Price Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381513","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381513?lang=en_us&edition=fundamental","pubTime":"2025-02-27 03:30","pubTimestamp":1740598213,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) shareholders that were waiting for something to happen have been dealt a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint-pharmaceuticals/news/eyepoint-pharmaceuticals-inc-nasdaqeypt-may-have-run-too-fas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TSYW.SI","BK4567","BK4585","LU2095319765.USD","IE00BFXG0V08.USD","SQQQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR",".IXIC","MNQmain","BK4007","USAW.SI","NQmain","NVIW.SI","PSQ","BK4588","QID","EYPT","NDAQ","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","LU2210149790.SGD","IE00B3QW5Z07.USD","TQQQ","QLD","IE00B5TLWC47.USD","FAST","USJW.SI","IE00BYQQ9H92.USD","LU2210150020.SGD","IE00BKPKM429.USD","BK4104"],"gpt_icon":1},{"id":"2514839696","title":"EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839696","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839696?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Feb. 26, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, March 5, 2025 to report its fourth quarter and full-year 2024 financial results and highlight recent corporate developments.Pipeline programs include EYP-2301, a TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The proven Durasert drug delivery technology has been safely administered to thousands of patient eyes across four U.S. FDA approved products in multiple disease indications. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.DURAVYU has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA appr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-report-fourth-quarter-full-120000381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4588","BK4007","LU0109394709.USD","EYPT","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514809843","title":"EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809843","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809843?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"– Company presentation scheduled on Tuesday, March 4th at 9:10am ET –。– EyePoint to provide enrollment update for ongoing DURAVYU Phase 3 pivotal program in wet AMD and additional subgroup analyses from Phase 2 VERONA clinical trial in DME–。WATERTOWN, Mass., Feb. 25, 2025  -- EyePoint Pharmaceuticals, Inc. , a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., EyePoint’s President and CEO, will present an update on enrollment for its ongoing Phase 3 pivotal program of DURAVYU in wet age-related macular degeneration  and additional subgroup analyses for the Phase 2 VERONA trial for DURAVYU in diabetic macular edema  at the TD Cowen 45th Annual Health Care Conference.Cowen 45th Annual Health Care ConferenceForum: Corporate PresentationDate: Tuesday, March 4, 2025Time: 9:10 a.m. ET. DURAVYU has been conditionally accepted by the FDA as the proprietary name for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eyepoint-present-corporate-td-cowen-120000522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4554","LU1064131342.USD","LU1951198990.SGD","LU1951200564.SGD","LU0320765992.SGD","COWN","GFS","LU2098885051.SGD","BK4575","LU0082616367.USD","LU2054465674.USD","LU2360106780.USD","LU1880398554.USD","LU0823434740.USD","BK4532","BK4512","LU0719512351.SGD","LU0823421416.USD","BK4529","IE0004445239.USD","LU0109394709.USD","LU2458330169.SGD","BK4127","BK4207","LU1988902786.USD","LU2458330243.SGD","LU2264538146.SGD","LU0109392836.USD","EYPT","BK4543","BK4588","LU1242518857.USD","LU1803068979.SGD","LU0979878070.USD","TD","LU1880398471.USD","LU0127658192.USD","LU2250418816.HKD","LU1242518931.SGD","IE00B5949003.HKD","LU1303367103.USD","LU1923623000.USD","BK4534","BK4566","IE00BMPRXR70.SGD","LU1852331112.SGD","IE0009356076.USD","LU0390134368.USD","LU0889565833.HKD"],"gpt_icon":1},{"id":"2512941161","title":"EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512941161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512941161?lang=en_us&edition=fundamental","pubTime":"2025-02-17 20:00","pubTimestamp":1739793600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250217:nTUA3SQGGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYPT","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","LU0109394709.USD","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"EYPT","fiscalQuarterEnding":"2025/03","expectedEps":-0.65,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-03-05","symbol":"EYPT","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"pre","actualEps":-0.64},{"market":"US","date":"2024-11-07","symbol":"EYPT","fiscalQuarterEnding":"2024/09","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-08-07","symbol":"EYPT","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2024-05-08","symbol":"EYPT","fiscalQuarterEnding":"2024/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EYPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6923,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6923,"analysts":13,"updateTime":1736481600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EYPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EYPT","date":"2025-05-13","current":-2.742512,"percent":0.682114,"low":-17.174537,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"high":-0.764844,"avg":-5.087871,"sd":3.282244,"marketCap":402548655},"quantilePoints":[{"date":"2020-05-15","current":-1.967188,"twenty":-4.129491,"median":-2.673684,"eighty":8.313039,"marketCap":99793464},{"date":"2020-05-22","current":-2.163906,"twenty":-4.053534,"median":-2.669984,"eighty":8.313039,"marketCap":109772810},{"date":"2020-05-29","current":-2.114727,"twenty":-4.031446,"median":-2.655853,"eighty":8.313039,"marketCap":107277973},{"date":"2020-06-05","current":-2.020056,"twenty":-3.86974,"median":-2.63576,"eighty":8.313039,"marketCap":102475413},{"date":"2020-06-12","current":-2.030138,"twenty":-3.770824,"median":-2.625354,"eighty":8.313039,"marketCap":102986854},{"date":"2020-06-19","current":-2.178906,"twenty":-3.703766,"median":-2.608156,"eighty":8.313039,"marketCap":110533735},{"date":"2020-06-26","current":-1.940139,"twenty":-3.621507,"median":-2.601703,"eighty":8.313039,"marketCap":98421303},{"date":"2020-07-02","current":-1.788911,"twenty":-3.593653,"median":-2.583964,"eighty":8.313039,"marketCap":90749681},{"date":"2020-07-10","current":-1.844238,"twenty":-3.568662,"median":-2.560659,"eighty":8.313039,"marketCap":93556372},{"date":"2020-07-17","current":-1.797518,"twenty":-3.557498,"median":-2.53573,"eighty":8.313039,"marketCap":91186277},{"date":"2020-07-24","current":-1.794075,"twenty":-3.517895,"median":-2.520652,"eighty":8.313039,"marketCap":91011639},{"date":"2020-07-31","current":-1.745879,"twenty":-3.498799,"median":-2.498114,"eighty":8.313039,"marketCap":88566699},{"date":"2020-08-07","current":-1.679767,"twenty":-3.461955,"median":-2.481381,"eighty":8.313039,"marketCap":87651942},{"date":"2020-08-14","current":-1.463797,"twenty":-3.43868,"median":-2.45699,"eighty":8.313039,"marketCap":76382406},{"date":"2020-08-21","current":-1.619296,"twenty":-3.420624,"median":-2.443093,"eighty":8.313039,"marketCap":84496472},{"date":"2020-08-28","current":-1.346933,"twenty":-3.40898,"median":-2.436189,"eighty":8.313039,"marketCap":70284335},{"date":"2020-09-04","current":-1.175837,"twenty":-3.391841,"median":-2.423704,"eighty":8.313039,"marketCap":61356359},{"date":"2020-09-11","current":-1.207513,"twenty":-3.382893,"median":-2.419615,"eighty":8.313039,"marketCap":63009224},{"date":"2020-09-18","current":-1.417964,"twenty":-3.36447,"median":-2.417412,"eighty":8.313039,"marketCap":73990760},{"date":"2020-09-25","current":-1.352693,"twenty":-3.340822,"median":-2.404314,"eighty":8.313039,"marketCap":70584856},{"date":"2020-10-02","current":-1.218791,"twenty":-3.319236,"median":-2.397965,"eighty":8.313039,"marketCap":63597744},{"date":"2020-10-09","current":-1.350942,"twenty":-3.303186,"median":-2.384452,"eighty":8.313039,"marketCap":70493486},{"date":"2020-10-16","current":-1.23083,"twenty":-3.283504,"median":-2.369413,"eighty":8.313039,"marketCap":64225934},{"date":"2020-10-23","current":-1.175454,"twenty":-3.25648,"median":-2.362921,"eighty":8.313039,"marketCap":61336369},{"date":"2020-10-30","current":-0.959078,"twenty":-3.240625,"median":-2.348435,"eighty":8.313039,"marketCap":50045661},{"date":"2020-11-06","current":-1.324675,"twenty":-3.216801,"median":-2.346145,"eighty":8.313039,"marketCap":53430757},{"date":"2020-11-13","current":-1.590108,"twenty":-3.216801,"median":-2.346145,"eighty":-0.9982,"marketCap":64137000},{"date":"2020-11-20","current":-1.543141,"twenty":-3.216801,"median":-2.346145,"eighty":-1.171499,"marketCap":62242598},{"date":"2020-11-27","current":-1.919231,"twenty":-3.216801,"median":-2.346145,"eighty":-1.200272,"marketCap":77412169},{"date":"2020-12-04","current":-1.842732,"twenty":-3.216801,"median":-2.346145,"eighty":-1.222823,"marketCap":74326589},{"date":"2020-12-11","current":-1.601713,"twenty":-3.216801,"median":-2.346145,"eighty":-1.241396,"marketCap":64605100},{"date":"2020-12-18","current":-1.740503,"twenty":-3.216801,"median":-2.346145,"eighty":-1.260673,"marketCap":70203200},{"date":"2020-12-24","current":-1.871791,"twenty":-3.216801,"median":-2.346145,"eighty":-1.277689,"marketCap":75498700},{"date":"2020-12-31","current":-2.468214,"twenty":-3.216801,"median":-2.346145,"eighty":-1.288397,"marketCap":99555400},{"date":"2021-01-08","current":-4.654737,"twenty":-3.240625,"median":-2.348896,"eighty":-1.298508,"marketCap":187748803},{"date":"2021-01-15","current":-4.916121,"twenty":-3.25648,"median":-2.365535,"eighty":-1.340948,"marketCap":198291759},{"date":"2021-01-22","current":-4.456923,"twenty":-3.283504,"median":-2.369413,"eighty":-1.352343,"marketCap":179770001},{"date":"2021-01-29","current":-5.042176,"twenty":-3.301349,"median":-2.384452,"eighty":-1.389848,"marketCap":203376163},{"date":"2021-02-05","current":-9.458126,"twenty":-3.31529,"median":-2.397965,"eighty":-1.422978,"marketCap":381493495},{"date":"2021-02-12","current":-9.493708,"twenty":-3.337373,"median":-2.404314,"eighty":-1.474613,"marketCap":382928703},{"date":"2021-02-19","current":-9.436817,"twenty":-3.354884,"median":-2.417412,"eighty":-1.493755,"marketCap":380633999},{"date":"2021-02-26","current":-7.687414,"twenty":-3.372729,"median":-2.418057,"eighty":-1.53113,"marketCap":310071856},{"date":"2021-03-05","current":-5.964997,"twenty":-3.391081,"median":-2.423704,"eighty":-1.551042,"marketCap":270775053},{"date":"2021-03-12","current":-7.097677,"twenty":-3.408419,"median":-2.436237,"eighty":-1.575196,"marketCap":322191934},{"date":"2021-03-19","current":-6.679794,"twenty":-3.417351,"median":-2.443093,"eighty":-1.593719,"marketCap":303222561},{"date":"2021-03-26","current":-6.318895,"twenty":-3.431949,"median":-2.45699,"eighty":-1.616992,"marketCap":286839920},{"date":"2021-04-01","current":-6.844414,"twenty":-3.459804,"median":-2.473797,"eighty":-1.642233,"marketCap":310695344},{"date":"2021-04-09","current":-6.33789,"twenty":-3.476049,"median":-2.49355,"eighty":-1.660834,"marketCap":287702164},{"date":"2021-04-16","current":-5.93267,"twenty":-3.509728,"median":-2.517525,"eighty":-1.676541,"marketCap":269307620},{"date":"2021-04-23","current":-6.173269,"twenty":-3.546897,"median":-2.53573,"eighty":-1.693188,"marketCap":280229381},{"date":"2021-04-30","current":-6.768436,"twenty":-3.561832,"median":-2.550655,"eighty":-1.703972,"marketCap":307246367},{"date":"2021-05-07","current":-6.290831,"twenty":-3.585661,"median":-2.577992,"eighty":-1.725619,"marketCap":279941966},{"date":"2021-05-14","current":-5.728919,"twenty":-3.617777,"median":-2.601703,"eighty":-1.736213,"marketCap":254936883},{"date":"2021-05-21","current":-6.038939,"twenty":-3.688868,"median":-2.606167,"eighty":-1.747012,"marketCap":268732791},{"date":"2021-05-28","current":-6.34896,"twenty":-3.758867,"median":-2.625354,"eighty":-1.757896,"marketCap":282528699},{"date":"2021-06-04","current":-5.916223,"twenty":-3.833087,"median":-2.633765,"eighty":-1.757896,"marketCap":263271911},{"date":"2021-06-11","current":-6.13582,"twenty":-3.971601,"median":-2.648063,"eighty":-1.769753,"marketCap":273044012},{"date":"2021-06-18","current":-6.168114,"twenty":-4.031446,"median":-2.667311,"eighty":-1.776996,"marketCap":274481086},{"date":"2021-06-25","current":-6.148738,"twenty":-4.076439,"median":-2.672658,"eighty":-1.784872,"marketCap":273618842},{"date":"2021-07-02","current":-5.696625,"twenty":-4.139513,"median":-2.68536,"eighty":-1.794961,"marketCap":253499809},{"date":"2021-07-09","current":-5.199301,"twenty":-4.174872,"median":-2.694091,"eighty":-1.80403,"marketCap":231368873},{"date":"2021-07-16","current":-4.960326,"twenty":-4.238237,"median":-2.704008,"eighty":-1.826995,"marketCap":220734528},{"date":"2021-07-23","current":-5.322017,"twenty":-4.294025,"median":-2.711822,"eighty":-1.843597,"marketCap":236829754},{"date":"2021-07-30","current":-5.309099,"twenty":-4.346909,"median":-2.719962,"eighty":-1.858853,"marketCap":236254924},{"date":"2021-08-06","current":-6.37565,"twenty":-4.370091,"median":-2.731788,"eighty":-1.874633,"marketCap":264972003},{"date":"2021-08-13","current":-7.164818,"twenty":-4.402389,"median":-2.736518,"eighty":-1.891961,"marketCap":297769841},{"date":"2021-08-20","current":-7.06098,"twenty":-4.441277,"median":-2.741305,"eighty":-1.914408,"marketCap":293454336},{"date":"2021-08-27","current":-6.964065,"twenty":-4.472799,"median":-2.743614,"eighty":-1.930259,"marketCap":289426531},{"date":"2021-09-03","current":-7.628628,"twenty":-4.546098,"median":-2.75544,"eighty":-1.941719,"marketCap":317045763},{"date":"2021-09-10","current":-7.102515,"twenty":-4.61979,"median":-2.759953,"eighty":-1.956547,"marketCap":295180538},{"date":"2021-09-17","current":-7.642473,"twenty":-4.694611,"median":-2.760901,"eighty":-1.971028,"marketCap":317621164},{"date":"2021-09-24","current":-8.113205,"twenty":-4.731269,"median":-2.77201,"eighty":-1.988007,"marketCap":337184786},{"date":"2021-10-01","current":-7.760156,"twenty":-4.841039,"median":-2.78384,"eighty":-1.998647,"marketCap":322512069},{"date":"2021-10-08","current":-7.137128,"twenty":-4.919907,"median":-2.790917,"eighty":-2.015619,"marketCap":296619040},{"date":"2021-10-15","current":-7.919374,"twenty":-4.938321,"median":-2.79725,"eighty":-2.019761,"marketCap":329129177},{"date":"2021-10-22","current":-8.313958,"twenty":-4.971427,"median":-2.804116,"eighty":-2.02816,"marketCap":345528096},{"date":"2021-10-29","current":-7.940141,"twenty":-5.098544,"median":-2.833605,"eighty":-2.028584,"marketCap":329992278},{"date":"2021-11-05","current":-7.455146,"twenty":-5.185586,"median":-2.834547,"eighty":-2.038548,"marketCap":405962535},{"date":"2021-11-12","current":-7.40231,"twenty":-5.288363,"median":-2.838221,"eighty":-2.041297,"marketCap":403085408},{"date":"2021-11-19","current":-10.730609,"twenty":-5.348044,"median":-2.838221,"eighty":-2.041297,"marketCap":584324577},{"date":"2021-11-26","current":-10.288687,"twenty":-5.475735,"median":-2.838221,"eighty":-2.041297,"marketCap":560260166},{"date":"2021-12-03","current":-9.043837,"twenty":-5.543465,"median":-2.838221,"eighty":-2.041297,"marketCap":492473092},{"date":"2021-12-10","current":-9.050061,"twenty":-5.631762,"median":-2.838221,"eighty":-2.041297,"marketCap":492812027},{"date":"2021-12-17","current":-8.502327,"twenty":-5.718585,"median":-2.850463,"eighty":-2.041297,"marketCap":462985715},{"date":"2021-12-23","current":-8.43386,"twenty":-5.736973,"median":-2.850463,"eighty":-2.041297,"marketCap":459257426},{"date":"2021-12-31","current":-7.618483,"twenty":-5.783171,"median":-2.850463,"eighty":-2.041297,"marketCap":414856892},{"date":"2022-01-07","current":-8.782418,"twenty":-5.864553,"median":-2.850463,"eighty":-2.041984,"marketCap":478237807},{"date":"2022-01-14","current":-6.180681,"twenty":-5.916223,"median":-2.850463,"eighty":-2.041984,"marketCap":336562822},{"date":"2022-01-21","current":-5.439995,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":296229513},{"date":"2022-01-28","current":-5.40265,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":294195901},{"date":"2022-02-04","current":-5.813451,"twenty":-5.931903,"median":-2.850463,"eighty":-2.041984,"marketCap":316565635},{"date":"2022-02-11","current":-6.224251,"twenty":-5.976705,"median":-2.850463,"eighty":-2.041984,"marketCap":338935370},{"date":"2022-02-18","current":-5.639172,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":307075445},{"date":"2022-02-25","current":-5.801002,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":315887764},{"date":"2022-03-04","current":-6.637487,"twenty":-6.076834,"median":-2.850463,"eighty":-2.041984,"marketCap":387742063},{"date":"2022-03-11","current":-7.652837,"twenty":-6.099766,"median":-2.850463,"eighty":-2.041984,"marketCap":447055753},{"date":"2022-03-18","current":-7.447927,"twenty":-6.135388,"median":-2.850467,"eighty":-2.041984,"marketCap":435085578},{"date":"2022-03-25","current":-7.401305,"twenty":-6.148738,"median":-2.850472,"eighty":-2.041984,"marketCap":432362038},{"date":"2022-04-01","current":-7.080776,"twenty":-6.15825,"median":-2.850472,"eighty":-2.041984,"marketCap":413637698},{"date":"2022-04-08","current":-6.96422,"twenty":-6.180751,"median":-2.853843,"eighty":-2.041984,"marketCap":406828847},{"date":"2022-04-14","current":-7.395477,"twenty":-6.19313,"median":-2.860806,"eighty":-2.041984,"marketCap":432021595},{"date":"2022-04-22","current":-7.290577,"twenty":-6.210376,"median":-2.860806,"eighty":-2.041984,"marketCap":425893630},{"date":"2022-04-29","current":-6.585969,"twenty":-6.244501,"median":-2.860806,"eighty":-2.041984,"marketCap":384732546},{"date":"2022-05-06","current":-5.646366,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":378944534},{"date":"2022-05-13","current":-5.017301,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":336726095},{"date":"2022-05-20","current":-4.824523,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":323788187},{"date":"2022-05-27","current":-4.915839,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":329916670},{"date":"2022-06-03","current":-4.59116,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":308126508},{"date":"2022-06-10","current":-4.017899,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":269653253},{"date":"2022-06-17","current":-4.007753,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":268972311},{"date":"2022-06-24","current":-3.678001,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":246841678},{"date":"2022-07-01","current":-3.931656,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":263865242},{"date":"2022-07-08","current":-4.185311,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":280888806},{"date":"2022-07-15","current":-5.027447,"twenty":-6.277913,"median":-2.871843,"eighty":-2.041297,"marketCap":337407038},{"date":"2022-07-22","current":-5.428222,"twenty":-6.277913,"median":-2.876614,"eighty":-2.041297,"marketCap":364304269},{"date":"2022-07-29","current":-4.631745,"twenty":-6.277913,"median":-2.897069,"eighty":-2.041297,"marketCap":310850278},{"date":"2022-08-05","current":-4.689345,"twenty":-6.277913,"median":-2.902765,"eighty":-2.041297,"marketCap":358777096},{"date":"2022-08-12","current":-4.947637,"twenty":-6.277913,"median":-2.918529,"eighty":-2.041297,"marketCap":378538797},{"date":"2022-08-19","current":-4.680438,"twenty":-6.277913,"median":-2.955067,"eighty":-2.041297,"marketCap":358095658},{"date":"2022-08-26","current":-4.578012,"twenty":-6.277913,"median":-2.981219,"eighty":-2.041297,"marketCap":350259121},{"date":"2022-09-02","current":-4.123773,"twenty":-6.277913,"median":-3.01561,"eighty":-2.041297,"marketCap":315505784},{"date":"2022-09-09","current":-3.990174,"twenty":-6.277913,"median":-3.047288,"eighty":-2.041297,"marketCap":305284215},{"date":"2022-09-16","current":-3.638389,"twenty":-6.277913,"median":-3.074739,"eighty":-2.041297,"marketCap":278369506},{"date":"2022-09-23","current":-3.206414,"twenty":-6.277913,"median":-3.090207,"eighty":-2.041297,"marketCap":245319516},{"date":"2022-09-30","current":-3.522602,"twenty":-6.277913,"median":-3.110217,"eighty":-2.041297,"marketCap":269510746},{"date":"2022-10-07","current":-2.743265,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":209884474},{"date":"2022-10-14","current":-2.493877,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":190804068},{"date":"2022-10-21","current":-2.596305,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":198640663},{"date":"2022-10-28","current":-2.444891,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":187056130},{"date":"2022-11-04","current":-2.291539,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":179276232},{"date":"2022-11-11","current":-2.017077,"twenty":-6.277913,"median":-3.117347,"eighty":-2.037196,"marketCap":157803984},{"date":"2022-11-18","current":-1.568353,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":122698562},{"date":"2022-11-25","current":-1.44637,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":113155340},{"date":"2022-12-02","current":-1.476866,"twenty":-6.277913,"median":-3.117347,"eighty":-2.020056,"marketCap":115541146},{"date":"2022-12-09","current":-1.267752,"twenty":-6.277913,"median":-3.117347,"eighty":-2.016865,"marketCap":99181337},{"date":"2022-12-16","current":-1.076065,"twenty":-6.277913,"median":-3.117347,"eighty":-2.005257,"marketCap":84184846},{"date":"2022-12-23","current":-1.259039,"twenty":-6.277913,"median":-3.117347,"eighty":-1.998555,"marketCap":98499679},{"date":"2022-12-30","current":-1.524788,"twenty":-6.277913,"median":-3.117347,"eighty":-1.991624,"marketCap":119290269},{"date":"2023-01-06","current":-1.420231,"twenty":-6.277913,"median":-3.117347,"eighty":-1.975507,"marketCap":111110364},{"date":"2023-01-13","current":-2.195695,"twenty":-6.277913,"median":-3.117347,"eighty":-1.963772,"marketCap":171777987},{"date":"2023-01-20","current":-1.834102,"twenty":-6.277913,"median":-3.117347,"eighty":-1.951722,"marketCap":143489152},{"date":"2023-01-27","current":-2.060642,"twenty":-6.277913,"median":-3.110217,"eighty":-1.94839,"marketCap":161212277},{"date":"2023-02-03","current":-2.021433,"twenty":-6.277913,"median":-3.099225,"eighty":-1.94839,"marketCap":158144813},{"date":"2023-02-10","current":-1.768754,"twenty":-6.277913,"median":-3.099225,"eighty":-1.939746,"marketCap":138376712},{"date":"2023-02-17","current":-1.503005,"twenty":-6.277913,"median":-3.099225,"eighty":-1.928219,"marketCap":117586122},{"date":"2023-02-24","current":-1.428944,"twenty":-6.277913,"median":-3.099225,"eighty":-1.918005,"marketCap":111792023},{"date":"2023-03-03","current":-1.086611,"twenty":-6.277913,"median":-3.099225,"eighty":-1.903097,"marketCap":111110364},{"date":"2023-03-10","current":-0.811808,"twenty":-6.277913,"median":-3.099225,"eighty":-1.876527,"marketCap":83010660},{"date":"2023-03-17","current":-0.788326,"twenty":-6.277913,"median":-3.099225,"eighty":-1.862926,"marketCap":80609526},{"date":"2023-03-24","current":-0.764844,"twenty":-6.277913,"median":-3.099225,"eighty":-1.844212,"marketCap":78208391},{"date":"2023-03-31","current":-0.986247,"twenty":-6.277913,"median":-3.098122,"eighty":-1.833959,"marketCap":100847662},{"date":"2023-04-06","current":-1.014761,"twenty":-6.277913,"median":-3.099225,"eighty":-1.830785,"marketCap":103763326},{"date":"2023-04-14","current":-1.298223,"twenty":-6.277913,"median":-3.096321,"eighty":-1.818062,"marketCap":132748453},{"date":"2023-04-21","current":-1.905402,"twenty":-6.277913,"median":-3.074739,"eighty":-1.806764,"marketCap":194834939},{"date":"2023-04-28","current":-2.101645,"twenty":-6.277913,"median":-3.057645,"eighty":-1.806764,"marketCap":214901566},{"date":"2023-05-05","current":-2.270232,"twenty":-6.25452,"median":-3.0294,"eighty":-1.806764,"marketCap":232567058},{"date":"2023-05-12","current":-2.136295,"twenty":-6.25452,"median":-3.000653,"eighty":-1.806764,"marketCap":218846287},{"date":"2023-05-19","current":-2.052584,"twenty":-6.25452,"median":-2.918529,"eighty":-1.806764,"marketCap":210270806},{"date":"2023-05-26","current":-1.985615,"twenty":-6.25452,"median":-2.89721,"eighty":-1.806764,"marketCap":203410421},{"date":"2023-06-02","current":-1.995661,"twenty":-6.25452,"median":-2.88216,"eighty":-1.806764,"marketCap":204439478},{"date":"2023-06-09","current":-2.035842,"twenty":-6.25452,"median":-2.865856,"eighty":-1.806764,"marketCap":208555710},{"date":"2023-06-16","current":-2.27358,"twenty":-6.25452,"median":-2.836384,"eighty":-1.806764,"marketCap":232910077},{"date":"2023-06-23","current":-2.08272,"twenty":-6.25953,"median":-2.815898,"eighty":-1.806567,"marketCap":213357979},{"date":"2023-06-30","current":-2.752405,"twenty":-6.264539,"median":-2.79725,"eighty":-1.80637,"marketCap":281961831},{"date":"2023-07-07","current":-2.882993,"twenty":-6.219784,"median":-2.79725,"eighty":-1.80637,"marketCap":295339582},{"date":"2023-07-14","current":-3.63304,"twenty":-6.19313,"median":-2.79725,"eighty":-1.80637,"marketCap":372175897},{"date":"2023-07-21","current":-3.95114,"twenty":-6.180681,"median":-2.79725,"eighty":-1.80637,"marketCap":404762726},{"date":"2023-07-28","current":-3.515845,"twenty":-6.158749,"median":-2.79725,"eighty":-1.80637,"marketCap":360170223},{"date":"2023-08-04","current":-4.05643,"twenty":-6.148902,"median":-2.79725,"eighty":-1.8052,"marketCap":429803132},{"date":"2023-08-11","current":-4.629056,"twenty":-6.137112,"median":-2.79725,"eighty":-1.8052,"marketCap":490476296},{"date":"2023-08-18","current":-4.361614,"twenty":-6.101011,"median":-2.79725,"eighty":-1.8052,"marketCap":462139221},{"date":"2023-08-25","current":-3.800317,"twenty":-6.098107,"median":-2.79725,"eighty":-1.8052,"marketCap":402666346},{"date":"2023-09-01","current":-3.272036,"twenty":-6.067271,"median":-2.79725,"eighty":-1.8052,"marketCap":346691876},{"date":"2023-09-08","current":-3.321563,"twenty":-6.026618,"median":-2.79725,"eighty":-1.8052,"marketCap":351939482},{"date":"2023-09-15","current":-3.631927,"twenty":-5.954331,"median":-2.79725,"eighty":-1.8052,"marketCap":384824484},{"date":"2023-09-22","current":-2.756963,"twenty":-5.954331,"median":-2.790917,"eighty":-1.8052,"marketCap":292116767},{"date":"2023-09-29","current":-2.641402,"twenty":-5.954331,"median":-2.778602,"eighty":-1.8052,"marketCap":279872352},{"date":"2023-10-06","current":-2.793282,"twenty":-5.954331,"median":-2.768311,"eighty":-1.8052,"marketCap":295965012},{"date":"2023-10-13","current":-2.674419,"twenty":-5.954331,"median":-2.767265,"eighty":-1.8052,"marketCap":283370756},{"date":"2023-10-20","current":-2.476314,"twenty":-5.954331,"median":-2.759953,"eighty":-1.8052,"marketCap":262380330},{"date":"2023-10-27","current":-2.039467,"twenty":-5.962331,"median":-2.756201,"eighty":-1.801691,"marketCap":216093723},{"date":"2023-11-03","current":-2.570254,"twenty":-5.962331,"median":-2.752288,"eighty":-1.801691,"marketCap":257405759},{"date":"2023-11-10","current":-2.326979,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":233042251},{"date":"2023-11-17","current":-2.178898,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":218212289},{"date":"2023-11-24","current":-2.164795,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":216799912},{"date":"2023-12-01","current":-2.203578,"twenty":-5.962331,"median":-2.74344,"eighty":-1.801691,"marketCap":220683950},{"date":"2023-12-08","current":-9.955568,"twenty":-6.049293,"median":-2.752172,"eighty":-1.802861,"marketCap":997030242},{"date":"2023-12-15","current":-9.574831,"twenty":-6.092369,"median":-2.75544,"eighty":-1.802861,"marketCap":958900191},{"date":"2023-12-22","current":-9.77225,"twenty":-6.109725,"median":-2.759953,"eighty":-1.802861,"marketCap":978671329},{"date":"2023-12-29","current":-11.074277,"twenty":-6.140987,"median":-2.764196,"eighty":-1.806567,"marketCap":1109066691},{"date":"2024-01-05","current":-9.368011,"twenty":-6.14956,"median":-2.778602,"eighty":-1.80637,"marketCap":938187570},{"date":"2024-01-12","current":-9.570131,"twenty":-6.168114,"median":-2.793282,"eighty":-1.80637,"marketCap":958429449},{"date":"2024-01-19","current":-10.745245,"twenty":-6.181032,"median":-2.79725,"eighty":-1.8052,"marketCap":1076114794},{"date":"2024-01-26","current":-11.704138,"twenty":-6.200408,"median":-2.804116,"eighty":-1.80637,"marketCap":1172146036},{"date":"2024-02-02","current":-13.401003,"twenty":-6.254636,"median":-2.834547,"eighty":-1.80637,"marketCap":1342083674},{"date":"2024-02-09","current":-13.687731,"twenty":-6.30708,"median":-2.853195,"eighty":-1.80637,"marketCap":1370798898},{"date":"2024-02-16","current":-13.668929,"twenty":-6.37565,"median":-2.853195,"eighty":-1.80637,"marketCap":1368915933},{"date":"2024-02-23","current":-12.268193,"twenty":-6.417185,"median":-2.853195,"eighty":-1.80637,"marketCap":1228635001},{"date":"2024-03-01","current":-12.789944,"twenty":-6.540499,"median":-2.856467,"eighty":-1.806567,"marketCap":1280887294},{"date":"2024-03-08","current":-16.829528,"twenty":-6.600791,"median":-2.864789,"eighty":-1.806567,"marketCap":1191446432},{"date":"2024-03-15","current":-15.302231,"twenty":-6.677113,"median":-2.871843,"eighty":-1.806567,"marketCap":1083321418},{"date":"2024-03-22","current":-16.48474,"twenty":-6.761591,"median":-2.887382,"eighty":-1.806567,"marketCap":1167037148},{"date":"2024-03-28","current":-14.647627,"twenty":-6.81781,"median":-2.892586,"eighty":-1.806567,"marketCap":1036978781},{"date":"2024-04-05","current":-14.18307,"twenty":-6.857077,"median":-2.918529,"eighty":-1.80637,"marketCap":1004090458},{"date":"2024-04-12","current":-16.111686,"twenty":-6.901762,"median":-3.019122,"eighty":-1.80637,"marketCap":1140626828},{"date":"2024-04-19","current":-12.317803,"twenty":-6.964065,"median":-3.050414,"eighty":-1.807354,"marketCap":872038860},{"date":"2024-04-26","current":-11.374611,"twenty":-6.977129,"median":-3.092915,"eighty":-1.807507,"marketCap":805265598},{"date":"2024-05-03","current":-14.669933,"twenty":-6.99966,"median":-3.108194,"eighty":-1.807507,"marketCap":1038557911},{"date":"2024-05-10","current":-8.362276,"twenty":-7.014797,"median":-3.172728,"eighty":-1.811775,"marketCap":659909031},{"date":"2024-05-17","current":-8.263275,"twenty":-7.045704,"median":-3.193664,"eighty":-1.811775,"marketCap":652096375},{"date":"2024-05-24","current":-7.332667,"twenty":-7.080776,"median":-3.232956,"eighty":-1.817369,"marketCap":578657406},{"date":"2024-05-31","current":-7.095065,"twenty":-7.101547,"median":-3.286694,"eighty":-1.83021,"marketCap":559907031},{"date":"2024-06-07","current":-6.118256,"twenty":-7.101547,"median":-3.330137,"eighty":-1.834973,"marketCap":482822156},{"date":"2024-06-14","current":-6.131456,"twenty":-7.102515,"median":-3.412645,"eighty":-1.845001,"marketCap":483863843},{"date":"2024-06-21","current":-5.385649,"twenty":-7.102515,"median":-3.462472,"eighty":-1.863418,"marketCap":425008500},{"date":"2024-06-28","current":-5.775053,"twenty":-7.102515,"median":-3.473443,"eighty":-1.885785,"marketCap":455738281},{"date":"2024-07-05","current":-5.689252,"twenty":-7.102515,"median":-3.509148,"eighty":-1.903349,"marketCap":448967312},{"date":"2024-07-12","current":-6.54066,"twenty":-7.102515,"median":-3.561832,"eighty":-1.919277,"marketCap":516156156},{"date":"2024-07-15","current":-6.817862,"twenty":-7.102515,"median":-3.561832,"eighty":-1.920686,"marketCap":538031593},{"date":"2024-08-02","current":-6.025855,"twenty":-7.124873,"median":-3.608452,"eighty":-1.963141,"marketCap":475530343},{"date":"2024-08-09","current":-5.503143,"twenty":-7.124873,"median":-3.632484,"eighty":-1.96681,"marketCap":477788393},{"date":"2024-08-16","current":-5.054645,"twenty":-7.124873,"median":-3.645064,"eighty":-1.980482,"marketCap":438849322},{"date":"2024-08-23","current":-5.547781,"twenty":-7.124873,"median":-3.698817,"eighty":-1.980482,"marketCap":481663890},{"date":"2024-08-30","current":-5.375183,"twenty":-7.124873,"median":-3.810182,"eighty":-1.980482,"marketCap":466678791},{"date":"2024-09-06","current":-4.968346,"twenty":-7.124873,"median":-3.83418,"eighty":-1.980482,"marketCap":431356772},{"date":"2024-09-13","current":-5.473811,"twenty":-7.124873,"median":-3.903238,"eighty":-1.980482,"marketCap":475241704},{"date":"2024-09-20","current":-5.658737,"twenty":-7.124873,"median":-3.951544,"eighty":-1.980482,"marketCap":491297167},{"date":"2024-09-27","current":-4.97451,"twenty":-7.124873,"median":-3.986281,"eighty":-1.980482,"marketCap":431891954},{"date":"2024-10-04","current":-5.159436,"twenty":-7.124873,"median":-4.012982,"eighty":-1.980482,"marketCap":447947417},{"date":"2024-10-11","current":-5.079302,"twenty":-7.124873,"median":-4.052753,"eighty":-1.980482,"marketCap":440990050},{"date":"2024-10-18","current":-6.873084,"twenty":-7.124873,"median":-4.083441,"eighty":-1.980482,"marketCap":596728041},{"date":"2024-10-25","current":-5.892976,"twenty":-7.124873,"median":-4.137591,"eighty":-1.980482,"marketCap":511634087},{"date":"2024-10-31","current":-8.74412,"twenty":-7.137898,"median":-4.196959,"eighty":-1.980482,"marketCap":759173235},{"date":"2024-11-08","current":-7.626837,"twenty":-7.20923,"median":-4.361614,"eighty":-1.97961,"marketCap":789911501},{"date":"2024-11-15","current":-7.106109,"twenty":-7.272765,"median":-4.416406,"eighty":-1.97961,"marketCap":735979669},{"date":"2024-11-22","current":-5.656435,"twenty":-7.272765,"median":-4.456923,"eighty":-1.97961,"marketCap":585837010},{"date":"2024-11-29","current":-5.995144,"twenty":-7.272765,"median":-4.545502,"eighty":-1.97961,"marketCap":620917070},{"date":"2024-12-06","current":-5.527726,"twenty":-7.272765,"median":-4.586087,"eighty":-1.97961,"marketCap":572506587},{"date":"2024-12-13","current":-5.378694,"twenty":-7.272765,"median":-4.621598,"eighty":-1.97961,"marketCap":557071360},{"date":"2024-12-20","current":-4.823212,"twenty":-7.272765,"median":-4.654737,"eighty":-1.97961,"marketCap":499540061},{"date":"2024-12-27","current":-5.134824,"twenty":-7.272765,"median":-4.680438,"eighty":-1.97961,"marketCap":531813717},{"date":"2025-01-03","current":-5.439662,"twenty":-7.272765,"median":-4.688488,"eighty":-1.97961,"marketCap":563385771},{"date":"2025-01-10","current":-6.171273,"twenty":-7.274134,"median":-4.721011,"eighty":-1.978739,"marketCap":639158702},{"date":"2025-01-17","current":-4.924825,"twenty":-7.274134,"median":-4.757117,"eighty":-1.978739,"marketCap":510064079},{"date":"2025-01-24","current":-5.974822,"twenty":-7.274134,"median":-4.81202,"eighty":-1.978739,"marketCap":618812267},{"date":"2025-01-31","current":-5.45321,"twenty":-7.274134,"median":-4.825842,"eighty":-1.978739,"marketCap":564788974},{"date":"2025-02-07","current":-4.484503,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":464460001},{"date":"2025-02-14","current":-4.274504,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":442710363},{"date":"2025-02-21","current":-4.301601,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":445516768},{"date":"2025-02-28","current":-4.22031,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":437097553},{"date":"2025-03-07","current":-3.581647,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":468730143},{"date":"2025-03-14","current":-3.586899,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":469417430},{"date":"2025-03-21","current":-3.203526,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":419245436},{"date":"2025-03-28","current":-3.103744,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":406186971},{"date":"2025-04-04","current":-2.620589,"twenty":-7.275504,"median":-4.857083,"eighty":-1.986581,"marketCap":342956512},{"date":"2025-04-11","current":-2.520807,"twenty":-7.274134,"median":-4.853805,"eighty":-1.998664,"marketCap":329898048},{"date":"2025-04-17","current":-2.914683,"twenty":-7.274134,"median":-4.853805,"eighty":-2.003697,"marketCap":381444618},{"date":"2025-04-25","current":-3.4346,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":449486090},{"date":"2025-05-02","current":-3.744449,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":490036058},{"date":"2025-05-09","current":-2.859698,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":419749277},{"date":"2025-05-13","current":-2.742512,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":402548655}],"updateTime":1747269522653}}}